56
Views
6
CrossRef citations to date
0
Altmetric
Original Research

LncRNA TP73-AS1 Activates TGF-β1 to Promote the Migration and Invasion of Colorectal Cancer Cell

, &
Pages 10523-10529 | Published online: 16 Dec 2019

References

  • Jemal A, Parkin DM, Bray F. Patterns of cancer incidence, mortality, and survival. Cancer Epidemiol Prev. 2017;8.
  • Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4 ):271–289. doi:10.3322/caac.v66.427253694
  • Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3 ):177–193. doi:10.3322/caac.2139528248415
  • Marijnen CA, Kapiteijn E, van de Velde CJ, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2002;20(3 ):817–825. doi:10.1200/JCO.20.3.81711821466
  • Glynne-Jones R, Debus J. Improving chemoradiotherapy in rectal cancer. Oncologist. 2001;6 Suppl 4:29–34. doi:10.1634/theoncologist.6-suppl_4-29
  • Bockelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncol. 2015;54(1 ):5–16. doi:10.3109/0284186X.2014.97583925430983
  • Carethers JM, Jung BH. Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology. 2015;149(5 ):1177–1190 e1173. doi:10.1053/j.gastro.2015.06.04726216840
  • Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4 ):452–463. doi:10.1016/j.ccell.2016.03.01027070700
  • Evans JR, Feng FY, Chinnaiyan AM. The bright side of dark matter: lncRNAs in cancer. J Clin Invest. 2016;126(8 ):2775–2782. doi:10.1172/JCI8442127479746
  • Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2013;26(2 ):155–165. doi:10.1038/modpathol.2012.16022996375
  • Chen X, Zhou Y, Liu S, et al. LncRNA TP73-AS1 predicts poor prognosis and functions as oncogenic lncRNA in osteosarcoma. J Cell Biochem. 2018.
  • Tuo Z, Zhang J, Xue W. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway. Biochem Biophys Res Commun. 2018;499(4 ):875–881. doi:10.1016/j.bbrc.2018.04.01029625110
  • Jia Z, Peng J, Yang Z, et al. Long non-coding RNA TP73‑AS1 promotes colorectal cancer proliferation by acting as a ceRNA for miR‑103 to regulate PTEN expression. Gene. 2019;685:222–229. doi:10.1016/j.gene.2018.11.07230472379
  • Cai Y, Yan P, Zhang G, Yang W, Wang H, Cheng X. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFalpha. Cancer Biomark. 2018;23(1 ):145–156. doi:10.3233/CBM-18150330010111
  • Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 2001;29(2 ):117–129.11586292
  • Akhurst RJ, Derynck R. TGF-beta signaling in cancer – a double-edged sword. Trends Cell Biol. 2001;11(11 ):S44–S51. doi:10.1016/s0962-8924(01)02130-411684442
  • Song J. EMT or apoptosis: a decision for TGF-beta. Cell Res. 2007;17(4 ):289–290. doi:10.1038/cr.2007.2517426696
  • Katsuno Y, Lamouille S, Derynck R. TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol. 2013;25(1 ):76–84. doi:10.1097/CCO.0b013e32835b637123197193
  • Lei Z, Xu G, Wang L, et al. MiR-142-3p represses TGF-beta-induced growth inhibition through repression of TGFbetaR1 in non-small cell lung cancer. FASEB J. 2014;28(6 ):2696–2704. doi:10.1096/fj.13-24728824558198
  • Yang G, Song R, Wang L, Wu X. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142. Biomed Pharmacother. 2018;103:1238–1245. doi:10.1016/j.biopha.2018.04.14629864904